Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 May 15;31(10):955-956.
doi: 10.1101/gad.302364.117.

p53: master of life, death, and the epigenome

Affiliations
Comment

p53: master of life, death, and the epigenome

Oleg Laptenko et al. Genes Dev. .

Abstract

Long understood as a bona fide tumor suppressor that safeguards the integrity of the genome via regulating numerous cellular outcomes, p53 may also exert its decisive and versatile functions by controlling DNA methylation. In this issue of Genes & Development, Tovy and colleagues (pp. 959-972) report that, in naïve mouse embryonic stem cells (ESCs), p53 controls DNA methylation homeostasis by regulating the expression of key counteracting components of the DNA methylation machinery. Their findings indicate that p53 may exert its "guardian of genome" duties at least in part via safeguarding the epigenome of ESCs.

Keywords: DNA methylation; p53; stem cells.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
p53 keeps DNA methylation in balance in naïve ESCs. The relative degree of DNA methylation in nuclei (shown schematically as an inner circle inside the bigger oval representing the cell) is kept under control by p53 that down-regulates Dnmt3a and Dnmt3b DNMTs responsible for de novo DNA methylation and up-regulates Tet1 and Tet2 components of demethylation machinery. This balance is perturbed by loss of functional p53 in ESCs with the subsequent stochastic increase in DNA methylation and clonal heterogeneity in both naïve ESCs and the differentiated progenitors.

Comment on

References

    1. Bibikova M, Chudin E, Wu B, Zhou L, Garcia EW, Liu Y, Shin S, Plaia TW, Auerbach JM, Arking DE, et al. 2006. Human embryonic stem cells have a unique epigenetic signature. Genome Res 16: 1075–1083. - PMC - PubMed
    1. Cedar H, Bergman Y. 2012. Programming of DNA methylation patterns. Annu Rev Biochem 81: 97–117. - PubMed
    1. Kribelbauer JF, Laptenko O, Chen S, Martini GD, Freed-Pastor W, Prives C, Mann RS, Bussemaker HJ. 2017. Quantitative analysis of the DNA methylation sensitivity of transcription factor complexes. Cell Rep 10.1016/j.celrep.2017.05.069. - DOI - PMC - PubMed
    1. Krizhanovsky V, Lowe SW. 2009. Stem cells: The promises and perils of p53. Nature 460: 1085–1086. - PMC - PubMed
    1. Levine AJ, Greenbaum B. 2012. The maintenance of epigenetic states by p53: the guardian of the epigenome. Oncotarget 3: 1503–1504. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources